Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q3 2025 · 10-Q
Revenue$183.00K$183.00K+169.1% vs Q3 2024 Net Income-$3.47M-$3.47MN/M vs Q3 2024 EPS, diluted—
Gross Profit$169,000+148.5% Operating Income-$3,579,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,844,000N/M Margins · derivedGross margin92.3%−7.7 pt vs Q3 2024
Operating margin-1955.7%+4597.2 pt vs Q3 2024
Net margin-1897.3%+4688.0 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end